Arterra Bioscience reduces profit in half-year; production value down

(Alliance News) - Arterra Bioscience Spa on Thursday reported that it ended the half-year with a net profit of EUR200,000, down from EUR700,000 in the same period last year.

As of June 30, value of production stood at EUR2.1 million, down 23 percent from the first half of 2022, when it stood at EUR2.7 million.

Ebitda was EUR400,000, down 70% from the first half of 2022, while Ebit was EUR104,000 as of June 30.

Net financial position is EUR5.5 million cash, essentially unchanged from EUR5.5 million as of Dec. 31, 2022.

Arterra Bioscience trades flat at EUR1.67 per share.

By Claudia Cavaliere, Alliance News reporter

Comments and questions to [e-mail]

Copyright 2023 Alliance News IS Italian Service Ltd. All rights reserved.